ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Down 6.9

2 days ago · Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) were down 6.9% on Tuesday . The company traded as low as $16.64 and last traded at $16.67. …

9%
OFF

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Down 6.9

1 week from now

2 days ago · Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) were down 6.9% on Tuesday . The company traded as low as $16.64 and last traded at $16.67. …

marketbeat.com

9%
OFF

ACADIA Pharmaceuticals (ACAD) News Today - MarketBeat

1 week from now

3 days ago · Fmr LLC decreased its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 95.9% during the 3rd quarter, according to the company in …

marketbeat.com

9%
OFF

ACADIA Pharmaceuticals (NASDAQ:ACAD) Trading Down 2.9

1 week from now

Dec 19, 2024 · ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) traded down 2.9% during trading on Thursday . The company traded as low as $16.41 and last traded at …

marketbeat.com

19%
OFF

Further Weakness As ACADIA Pharmaceuticals (NASDAQ:ACAD) …

1 week from now

Jan 8, 2025 · ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shareholders should be happy to see the share price up 19% in the last quarter.But don't envy holders -- looking back over 5 …

yahoo.com

9%
OFF

Acadia Pharmaceuticals (NASDAQ: ACAD) - The Motley Fool

1 week from now

Real time Acadia Pharmaceuticals (ACAD) stock price quote, stock graph, news & analysis. ... Acadia Pharmaceuticals (NASDAQ: ACAD) $17.26 (-1.9%) -$0.34 ... These two growth stocks …

fool.com

$20
OFF

Guggenheim Downgrades Acadia Pharmaceuticals To Neutral On

1 week from now

Jan 3, 2025 · As previously reported, Guggenheim downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Buy with a price target of $20, down from $23. The firm, which views Acadia as …

nasdaq.com

$16
OFF

Acadia Pharmaceuticals Reports First Quarter 2024 Financial …

1 week from now

Mar 31, 2024 · For the first quarter of 2024, Acadia reported net income of $16.6 million, or $0.10 per common share, compared to a net loss of $43.0 million, or $0.27 per common share, for …

acadia.com

$16.69
OFF

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap Up – Here’s …

1 week from now

Jan 2, 2025 · ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) shares gapped up before the market opened on Tuesday .The stock had previously closed at $16.69, but …

etfdailynews.com

$18.66
OFF

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap Down - ETF …

1 week from now

Jan 5, 2025 · ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price gapped down before the market opened on Friday .The stock had previously closed at $18.66, …

etfdailynews.com

44%
OFF

Why Acadia Pharmaceuticals Stock Is Crashing Today

1 week from now

Mar 9, 2021 · Shares of the mid-cap biopharma Acadia Pharmaceuticals (NASDAQ: ACAD) fell by as much as 44% in pre-market trading Tuesday morning. The drugmaker's stock is crashing …

nasdaq.com

5%
OFF

Acadia Pharmaceuticals Reports Second Quarter 2021 Financial …

1 week from now

Jun 30, 2021 · 2Q21 net sales of $115.2 million , a 5% increase over 2Q20 - Fiscal year 2021 revenue guidance reduced to $480 to $515 million - Type A meeting held with FDA regarding …

acadia.com

6%
OFF

ACAD Seeks EU Nod For Rett Syndrome Drug, Outlines 2025 …

1 week from now

9 hours ago · Acadia Pharmaceuticals ACAD announced that it has submitted a marketing authorization ... shares of Acadia have plunged 41.6% compared with the industry’s decline of …

yahoo.com

33%
OFF

ACADIA Pharmaceuticals (ACAD) Stock Price, News & Analysis

1 week from now

2 days ago · Earnings for ACADIA Pharmaceuticals are expected to grow by 12.33% in the coming year, from $0.73 to $0.82 per share. Price to Earnings Ratio vs. the Market The P/E …

marketbeat.com

$16.69
OFF

ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Gap Up

1 week from now

Dec 31, 2024 · ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $16.69, but opened at …

marketbeat.com

FAQs about ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Down 6.9 Coupon?

What happened to Acadia Pharmaceuticals Inc (ACAD) stock before the market opened?

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $18.66, but opened at $18.25. ACADIA Pharmaceuticals shares last traded at $18.39, with a volume of 386,029 shares trading hands. ...

Should Acadia Pharmaceuticals Inc (ACAD) shareholders celebrate the recent bounce?

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shareholders should be happy to see the share price up 19% in the last quarter. But don't envy holders -- looking back over 5 years the returns have been really bad. Indeed, the share price is down 61% in the period. So we're not so sure if the recent bounce should be celebrated. ...

Is Acadia Pharmaceuticals a good stock to buy?

ACADIA Pharmaceuticals shareholders are down 43% for the year, but the market itself is up 26%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. ...

When did Acadia Pharmaceuticals (ACAD) release its quarterly earnings?

ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The biopharmaceutical company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.14 by $0.06. ...

Why did Acadia Pharmaceuticals lead a Biotech stock sell-off Wednesday?

Acadia Pharmaceuticals (ACAD) led a biotech stock sell-off on Wednesday after revenue from its Rett syndrome treatment missed expectations. Despite reporting encouraging second-quarter results with higher Nuplazid and Daybue sales, the company's stock price decreased significantly. ...

Will Acadia Pharmaceuticals Inc (Acadia) post earnings per share?

As a group, sell-side analysts expect that ACADIA Pharmaceuticals Inc. will post 0.73 earnings per share for the current year. In related news, insider James Kihara sold 4,073 shares of ACADIA Pharmaceuticals stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $16.81, for a total transaction of $68,467.13. ...